Staying Ahead of the Curve: New Therapeutic Agents in AML

Actions Panel

Registrations are closed

Thank you for registering for Staying Ahead of the Curve: New Therapeutic Agents in AML. An email confirming your registration for this educational activity will be sent to you shortly.

Staying Ahead of the Curve: New Therapeutic Agents in AML

Join Faculty Moderator Roland B. Walter, MD, PhD, MS on January 29, 2020!

When and where

Date and time

Location

Ruth’s Chris Steakhouse 1601 Van Ness Avenue San Francisco, CA 94109

Map and directions

How to get there

About this event

Tuesday, January 29, 2020

6:30 PM - 8:30 PM

Ruth’s Chris Steakhouse

San Francisco, CA

There is no fee to attend this educational activity.

UPCOMING MEETINGS :

Nashville, TN - https://amlsmallgroupnashville.eventbrite.com

PROGRAM OVERVIEW

The incidence of acute myeloid leukemia (AML)—the most common and lethal form of leukemia in adults—has been increasing due to an aging population, increased risk from environmental exposures, and treatment-related/secondary AML in survivors of young and childhood cancers. Members of the hematology/oncology care team are challenged to keep apprised of clinical data in AML, and work together to incorporate novel agents into their clinical practice and appropriately manage side effects of the newer therapies. This activity will offer insights into applying guideline-recommended assessment and treatment strategies into practice and how collaboration among clinicians in both community and academic settings can optimize outcomes for patients with AML.

FACULTY MODERATORS

Naval G. Daver, MD

Daniel A. Pollyea, MD, MSA

Roland B. Walter, MD, PhD, MS

Amer M. Zeidan, MBBS, MHS

TARGET AUDIENCE

Hematologists/oncologists, oncology nurse practitioners, and oncology physician assistants.

LEARNING OBJECTIVES

Upon completion of this activity, learners should be better able to:

  • SUMMARIZE mechanisms of action and safety/efficacy data of novel approved agents for AML
  • CREATE individualized assessment and treatment plans as a team for individuals with AML
  • IDENTIFY appropriate adverse event monitoring and supportive care strategies for individuals with AML
  • EVALUATE how measurable residual disease (MRD) assessment can be used in AML management

ACCREDITATION AND CREDIT DESIGNATION

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and Spire Learning. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians:

American Academy of CME, Inc., designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity providers responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Your points will be automatically submitted to the ABIM on your behalf; please allow 6-8 weeks for your points to display on the ABIM website.

CLAIMING MOC POINTS:

If you intend to claim MOC points for your participation, you will need to provide your unique ABIM ID when completing the activity evaluation. Physicians who do not know their ABIM ID can log in to the ABIM website at https://www.abim.org — your ABIM ID will appear next to your name.

Nurse Practitioners/Nurses:

The Academy designates this educational activity for 1.5 ANCC contact hours (including pharmacotherapeutic contact hours).

Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.5 contact hours.

Physician Assistants:

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit ™ from organizations accredited by ACCME or a recognized state medical society.

REGISTRATION

The Academy and Spire Learning fully comply with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Spire Learning at 973-605-2922 in order to receive service.

Per regulatory guidelines, the educational grant used to support this activity may only be used for medical professionals attending the activity. Our grant funding does not allow for participation by non-healthcare providers and/or guests.

Please preregister to attend this educational activity. Participants will be accommodated on a first-come, first-served basis.

There is no fee to attend this educational activity.

Event Contact

Spire Learning

5 Sylvan Way

Parsippany, NJ 07054

Phone: 973-605-2922

Web: www.spirelearning.com

Jointly provided by the American Academy of CME and Spire Learning.

Supported by an educational grant from Genentech, Inc.